James E Walls

US Patent:

20110196502, Aug 11, 2011

Filed:

Feb 1, 2011

Appl. No.:

13/019265

Inventors:

James A. Walls - Bethany CT, US

International Classification:

A61F 2/30
A61K 9/14
A61K 33/42
A61K 33/38
A61F 2/00
A61P 19/08
A61P 17/00
A61F 2/02
A61B 17/00

US Classification:

623 1811, 424484, 424602, 424618, 424486, 424423, 623 1111, 606 54

Abstract:

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.

US Patent:

41694651, Oct 2, 1979

Filed:

May 4, 1977

Appl. No.:

5/793513

Inventors:

James A. Walls - Branford CT
Robert P. Howard - E. Hartford CT

International Classification:

A61B 508

US Classification:

128719

Abstract:

A method and apparatus for obtaining non-invasive cardio-pulmonary measurements, without voluntary patient cooperation, by means of an inhalation indicator dilution rebreathing device having a valving system and test gas chamber connected to a volume ventilator, the valving system being operable to connect the ventilator directly to the patient for normal ventilation or to effect inhalation and exhalation of the test gas during the measurement cycle, the test gas being monitored and analyzed by a test instrument such as a mass spectrometer to ascertain the cardio-pulmonary parameters.

US Patent:

20220387676, Dec 8, 2022

Filed:

Aug 12, 2022

Appl. No.:

17/887085

Inventors:

- Beacon Falls CT, US
James A. WALLS - Beacon Falls CT, US

International Classification:

A61L 31/08
A61K 33/38
A61K 33/42
A61L 24/00
A61L 31/12
A61L 31/14
A61L 31/16
A61L 27/42
A61L 27/44
A61K 9/70
A61L 31/02

Abstract:

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.

US Patent:

20210205504, Jul 8, 2021

Filed:

Mar 21, 2021

Appl. No.:

17/207676

Inventors:

- Beacon Falls CT, US
James A. WALLS - Beacon Falls CT, US

International Classification:

A61L 31/08
A61K 33/38
A61K 33/42
A61L 24/00
A61L 31/12
A61L 31/14
A61L 31/16
A61L 27/42
A61L 27/44
A61K 9/70
A61L 31/02

Abstract:

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.

US Patent:

20190038814, Feb 7, 2019

Filed:

Oct 8, 2018

Appl. No.:

16/154600

Inventors:

- Bethany CT, US
James A. Walls - Bethany CT, US

International Classification:

A61L 31/08
A61L 24/00
A61L 31/16
A61L 27/42
A61L 27/44
A61L 31/02
A61L 31/12
A61L 31/14
A61K 9/70
A61K 33/38
A61K 33/42
A61F 2/28
A61B 17/86
A61F 2/32
A61F 2/44
A61F 2/46
A61F 2/30
A61L 27/10
A61B 17/60

Abstract:

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.

US Patent:

20170136156, May 18, 2017

Filed:

Jan 29, 2017

Appl. No.:

15/418739

Inventors:

- Bethany CT, US
James A. Walls - Bethany CT, US

International Classification:

A61L 31/08
A61L 31/02
A61L 31/16
A61L 31/14

Abstract:

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.

US Patent:

20140147487, May 29, 2014

Filed:

Jan 30, 2014

Appl. No.:

14/168975

Inventors:

- Bethany CT, US
James A. Walls - Bethany CT, US

Assignee:

AMxTek LLC - Bethany CT

International Classification:

A61K 9/70
A61K 33/42

US Classification:

424426, 424602

Abstract:

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.